Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
暂无分享，去创建一个
L. Recht | R. Stupp | M. Weller | N. Butowski | D. Tran | W. Wick | H. Hirte | G. Finocchiaro | D. O’Rourke | F. Iwamoto | J. Sampson | T. Keler | T. Davis | M. Yellin | M. Lim | C. Turner | M. Hamilton | J. Drappatz | J. Perry | L. Ashby | M. Wong | L. Mechtler | Jennifer A Green | S. Goldlust | Yi He